Use access key #2 to skip to page content.
$73.03 0.57 (0.79%)
7/3/2008 1:00 PM

Genzyme Corp (GENZ)

CAPS Rating:
*****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View All Commentary (GENZ)

Recs

3

Avatar Firesale (91.44) Submitted: 3/28/07 12:36 PM : Outperform Start Price: $59.88 GENZ Score: 33.15

Foward PE of 16.51, the company's sales have grown by 16.5% for the 12-month period, has "promising" products under development to treat genetic diseases, kidney disease and cancer among other conditions, and shares are down over 12%
since January."

Report this Post Replies: 0 | Reply

Featured Broker Partners